Literature DB >> 12514928

Single framework recombinant antibody fragments designed for protein chip applications.

Cornelia Steinhauer1, Christer Wingren, Ann-Christin Malmborg Hager, Carl A K Borrebaeck.   

Abstract

High-throughput proteomics, based on the microarray platform, requires stable, highly functional components that will yield a highly sensitive read-out of low abundance proteins. Although antibodies are the best characterized binding molecules for this purpose, only a fraction of them appear to behave satisfactorily in the chip format. Therefore, high demands need to be placed on their molecular design. In the present study, we have focused on recombinant antibody design based on a single framework for protein chip applications, aiming at defining crucial molecular probe parameters. Our results show that engineered human recombinant scFv antibody fragments that displayed appropriate biophysical properties (molecular [functional] stability in particular) can be generated, making them prime candidates for high-density antibody arrays. In fact, a superior framework that displays both multifaceted adsorption properties and very high functional stability over several months on chips (stored in a dried-out state) was identified. Taken together, designed scFv fragments based on a single molecular scaffold, readily accessible in large phage display libraries, can undoubtedly meet the requirements of probe content in antibody microarrays, particularly for global proteome analysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12514928

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  9 in total

1.  Conference report--protein microarrays in cancer and autoimmunity: tiny spots light up highlights of the ABRF 2004--integrating technologies in proteomics and genomics; February 28-March 2, 2004; Portland, Oregon.

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-04-09

2.  Molecular simulation of protein-surface interactions: benefits, problems, solutions, and future directions.

Authors:  Robert A Latour
Journal:  Biointerphases       Date:  2008-09       Impact factor: 2.456

3.  Specific and randomly derived immunoactive peptide mimotopes of mycobacterial antigens.

Authors:  Archna Sharma; Abhik Saha; Surajit Bhattacharjee; Subrata Majumdar; Sujoy K Das Gupta
Journal:  Clin Vaccine Immunol       Date:  2006-08-17

4.  Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases.

Authors:  Anders Carlsson; Christer Wingren; Malin Kristensson; Carsten Rose; Mårten Fernö; Håkan Olsson; Helena Jernström; Sara Ek; Elin Gustavsson; Christian Ingvar; Mattias Ohlsson; Carsten Peterson; Carl A K Borrebaeck
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

5.  Platform for high-throughput antibody selection using synthetically-designed antibody libraries.

Authors:  Melissa Batonick; Erika G Holland; Valeria Busygina; Dawn Alderman; Brian K Kay; Michael P Weiner; Margaret M Kiss
Journal:  N Biotechnol       Date:  2015-11-24       Impact factor: 5.079

6.  An improved method for the in vitro evolution of aptamers and applications in protein detection and purification.

Authors:  Michael B Murphy; Shirin T Fuller; Paul M Richardson; Sharon A Doyle
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

Review 7.  Antibody Fragments as Probe in Biosensor Development.

Authors:  Dirk Saerens; Lieven Huang; Kristien Bonroy; Serge Muyldermans
Journal:  Sensors (Basel)       Date:  2008-08-08       Impact factor: 3.576

Review 8.  Nanobodies as novel agents for disease diagnosis and therapy.

Authors:  Christina G Siontorou
Journal:  Int J Nanomedicine       Date:  2013-01-11

9.  A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma.

Authors:  Anna S Gerdtsson; Núria Malats; Anna Säll; Francisco X Real; Miquel Porta; Petter Skoog; Helena Persson; Christer Wingren; Carl A K Borrebaeck
Journal:  Int J Proteomics       Date:  2015-10-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.